Targeted Therapy (tucatinib & trastuzumab) for stage 4 CRC
My cancer had spread to liver and a lesion was found in lung. Standard folfox 6 cycles , two liver resections and then Radiation + Xeloda was the treatment protocol.My response was considered good at various stages. Next in the plan was rectal surgery to address the primary.
During February23 review and scans it was found that though liver was clear and primary had shrunk, new lesions have appeared in the lung. Now Drs have dropped the surgery plans.
I am to be given targeted therapy with a very recently FDA approved drug combination for Colorectal cancer ( Trastuzunab + Tucatinib). I am eligible for this since genetic structure of my tumor is HER2 …
Has anyone experienced such a situation i.e treatment with above meds